These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 8946151)

  • 41. Effects of insulin resistance and insulin secretion on the efficacy of interventions to retard development of type 2 diabetes mellitus: the DA Qing IGT and Diabetes Study.
    Li G; Hu Y; Yang W; Jiang Y; Wang J; Xiao J; Hu Z; Pan X; Howard BV; Bennett PH;
    Diabetes Res Clin Pract; 2002 Dec; 58(3):193-200. PubMed ID: 12413779
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Non-insulin-dependent diabetes mellitus in Mexico.
    Schulz LO; Weidensee RC
    Prog Food Nutr Sci; 1993; 17(2):99-117. PubMed ID: 8372229
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Re: a lifestyle intervention study in patients with diabetes or impaired glucose tolerance: translation of a research intervention into practice.
    Williams LB
    J Am Board Fam Med; 2010; 23(2):273; author reply 273-4. PubMed ID: 20207938
    [No Abstract]   [Full Text] [Related]  

  • 44. [Malmö Feasibility Study (Sweden)].
    Tsujii S
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():493-8. PubMed ID: 15779428
    [No Abstract]   [Full Text] [Related]  

  • 45. [The Da Qing IGT and Diabetes study].
    Ayame H
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():499-502. PubMed ID: 15779429
    [No Abstract]   [Full Text] [Related]  

  • 46. Early, detectable metabolic changes may predict later onset of diabetes. But monitoring changes in blood sugar, insulin sensitivity, and pancreas function could enable earlier intervention.
    Duke Med Health News; 2009 Sep; 15(9):6. PubMed ID: 19785080
    [No Abstract]   [Full Text] [Related]  

  • 47. Motivation for lifestyle changes to improve health in people with impaired glucose tolerance.
    Hansen E; Landstad BJ; Hellzén O; Svebak S
    Scand J Caring Sci; 2011 Sep; 25(3):484-90. PubMed ID: 21175731
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Shenzhu Tiaopi granule combined with lifestyle intervention therapy for impaired glucose tolerance: a randomized controlled trial.
    Fang Z; Zhao J; Shi G; Shu Y; Ni Y; Wang H; Ding L; Lu R; Li J; Zhu X; Cheng S; Zhang X; Liu Y; Wang J; Luo Y; Fan Q; Guo C; Jiang T; Wu Q; Fan L; Ling H; Cui L; Luo Y; Yang H; Anderson RM
    Complement Ther Med; 2014 Oct; 22(5):842-50. PubMed ID: 25440374
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Common polymorphisms in the genes regulating the early insulin signalling pathway: effects on weight change and the conversion from impaired glucose tolerance to Type 2 diabetes. The Finnish Diabetes Prevention Study.
    Laukkanen O; Pihlajamäki J; Lindström J; Eriksson J; Valle TT; Hämäläinen H; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Tuomilehto J; Uusitupa M; Laakso M;
    Diabetologia; 2004 May; 47(5):871-7. PubMed ID: 15127203
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The potential role of physical activity in the prevention of non-insulin-dependent diabetes mellitus: the epidemiological evidence.
    Kriska AM; Blair SN; Pereira MA
    Exerc Sport Sci Rev; 1994; 22():121-43. PubMed ID: 7925541
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Diabetes mellitus in the elderly].
    Oba K; Nakano H; Suzuki T; Metori S
    Nihon Rinsho; 1997 Nov; 55 Suppl():620-5. PubMed ID: 9434538
    [No Abstract]   [Full Text] [Related]  

  • 52. Economic implications of IGT intervention: the case of a "phantom alternative'?
    Gafni A
    Diabet Med; 1996; 13(3 Suppl 2):S25-8. PubMed ID: 8689859
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Study on Lifestyle Intervention and Impaired Glucose Tolerance Maastricht (SLIM): preliminary results after one year.
    Mensink M; Feskens EJ; Saris WH; De Bruin TW; Blaak EE
    Int J Obes Relat Metab Disord; 2003 Mar; 27(3):377-84. PubMed ID: 12629566
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Pathophysiology and management of impaired glucose tolerance and diabetes with metabolic syndrome].
    Ohara T
    Nihon Rinsho; 2006 Dec; 64 Suppl 9():428-32. PubMed ID: 17458257
    [No Abstract]   [Full Text] [Related]  

  • 55. Type 2 diabetes mellitus: the grand overview.
    Ratner RE
    Diabet Med; 1998; 15 Suppl 4():S4-7. PubMed ID: 9868984
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevention of type 2 diabetes in a primary healthcare setting: three-year results of lifestyle intervention in Japanese subjects with impaired glucose tolerance.
    Sakane N; Sato J; Tsushita K; Tsujii S; Kotani K; Tsuzaki K; Tominaga M; Kawazu S; Sato Y; Usui T; Kamae I; Yoshida T; Kiyohara Y; Sato S; Kuzuya H;
    BMC Public Health; 2011 Jan; 11(1):40. PubMed ID: 21235825
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Changing habits to delay diabetes.
    Tataranni PA; Bogardus C
    N Engl J Med; 2001 May; 344(18):1390-2. PubMed ID: 11333998
    [No Abstract]   [Full Text] [Related]  

  • 58. [Diet therapy for impaired glucose tolerance].
    Ogura M; Seino Y
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():503-8. PubMed ID: 15779430
    [No Abstract]   [Full Text] [Related]  

  • 59. Avoiding the slippery slope: preventing the development of diabetes in women with a history of gestational diabetes.
    Feig DS
    Diabetes Metab Res Rev; 2012 May; 28(4):317-20. PubMed ID: 22228687
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The internal and external cohort studies about impaired glucose tolerance].
    Shibazaki S; Nagai M
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():82-6. PubMed ID: 15779350
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.